Department of Urology, Shenzhen Second People's Hospital, Clinical Medicine College of Anhui Medical University, Shenzhen 518035, China.
Graduate School, Anhui Medical University, Hefei 230032, China.
Biosci Rep. 2019 Apr 12;39(4). doi: 10.1042/BSR20182372. Print 2019 Apr 30.
Long intergenic non-coding RNA p21 (lincRNA-p21) is down-regulated in some solid tumors. Glutamine catabolism plays an important role in cancer development. However, the role of lincRNA-p21 and its association with glutamine catabolism remain unknown in bladder cancer (BC). In the present study, we investigated the involvement of lincRNA-p21 and glutamine catabolism in BC cell growth and found that ectopic linRNA-p21 expression reduced the proliferation and growth of BIU87 and 5637 cells. Opposite results were observed in lincRNA-p21 silenced J82 and T24 cells. The expression of glutaminase (GLS), intracellular level of glutamate and α-Ketoglutarate (α-KG) were negatively regulated by lincRNA-p21. GLS overexpression reversed the suppressive function of lincRNA-p21 on BC cell growth and proliferation. In contrast, GLS reduction by siRNA blunted the viability of lincRNA-p21 lowly expressed BC cells. Furthermore, lincRNA-p21 and GLS abundance dictated the sensitivity of BC cells to bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) treatment. Importantly, reduced lincRNA-p21 expression and increased GLS mRNA level were observed in BC tissues compared with the normal tissues. Our results demonstrate that lincRNA-p21 suppresses the BC cell growth through inhibiting GLS and glutamine catabolism. Targeting this cascade may be a promising treatment strategy for BC patients.
长链非编码 RNA p21(lincRNA-p21)在一些实体瘤中下调。谷氨酰胺分解代谢在癌症发展中起着重要作用。然而,在膀胱癌(BC)中,lincRNA-p21 的作用及其与谷氨酰胺分解代谢的关系尚不清楚。在本研究中,我们研究了 lincRNA-p21 和谷氨酰胺分解代谢在 BC 细胞生长中的作用,发现异位 linRNA-p21 表达降低了 BIU87 和 5637 细胞的增殖和生长。在 lincRNA-p21 沉默的 J82 和 T24 细胞中观察到相反的结果。谷氨酰胺酶(GLS)的表达、细胞内谷氨酸和α-酮戊二酸(α-KG)水平受到 lincRNA-p21 的负调控。GLS 过表达逆转了 lincRNA-p21 对 BC 细胞生长和增殖的抑制作用。相反,siRNA 降低 GLS 表达削弱了 lincRNA-p21 低表达 BC 细胞的活力。此外,lincRNA-p21 和 GLS 的丰度决定了 BC 细胞对双-2-(5-苯乙酰胺基-1,2,4-噻二唑-2-基)乙硫醚(BPTES)治疗的敏感性。重要的是,与正常组织相比,BC 组织中 lincRNA-p21 表达降低和 GLS mRNA 水平升高。我们的研究结果表明,lincRNA-p21 通过抑制 GLS 和谷氨酰胺分解代谢来抑制 BC 细胞的生长。靶向该级联可能是 BC 患者的一种有前途的治疗策略。